ASSET PURCHASE AGREEMENT by and between Bellicum Pharmaceuticals, Inc. and The University of Texas M. D. Anderson Cancer Center Dated as of November 21, 2023Asset Purchase Agreement • November 22nd, 2023 • Bellicum Pharmaceuticals, Inc • Pharmaceutical preparations • Texas
Contract Type FiledNovember 22nd, 2023 Company Industry JurisdictionThis Asset Purchase Agreement (this “Agreement”) is made and executed as of November 21, 2023 (the “Execution Date”), by and between Bellicum Pharmaceuticals, Inc., a Delaware corporation (“Seller”) and The University of Texas M. D. Anderson Cancer Center, an institution of higher education and an agency of the State of Texas (“Purchaser”). Seller and Purchaser are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”